Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat
Standard
Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. / Roehl, Anna B; Funcke, Sandra; Becker, Michael M; Goetzenich, Andreas; Bleilevens, Christian; Rossaint, Rolf; Steendijk, Paul; Hein, Marc.
In: ANESTHESIOLOGY, Vol. 118, No. 6, 01.06.2013, p. 1385-94.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat
AU - Roehl, Anna B
AU - Funcke, Sandra
AU - Becker, Michael M
AU - Goetzenich, Andreas
AU - Bleilevens, Christian
AU - Rossaint, Rolf
AU - Steendijk, Paul
AU - Hein, Marc
PY - 2013/6/1
Y1 - 2013/6/1
N2 - BACKGROUND: Xenon and isoflurane are known to have cardioprotective properties. We tested the hypothesis that these anesthetics positively influence myocardial remodeling 28 days after experimental perioperative myocardial infarction and compared their effects.METHODS: A total of 60 male Sprague-Dawley rats were subjected to 60 min of coronary artery occlusion and 120 min of reperfusion. Prior to ischemia, the animals were randomized for the different narcotic regimes (0.6 vol% isoflurane, 70 vol% xenon, or intraperitoneal injection of s-ketamine). Acute injury was quantified by echocardiography and troponin I. After 4 weeks, left ventricular function was assessed by conductance catheter to quantify hemodynamic compromise. Cardiac remodeling was characterized by quantification of dilatation, hypertrophy, fibrosis, capillary density, apoptosis, and expression of fetal genes (α/β myosin heavy chains, α-skeletal actin, periostin, and sarco/endoplasmic reticulum Ca2+-ATPase).RESULTS: Whereas xenon and isoflurane impeded the acute effects of ischemia-reperfusion on hemodynamics and myocardial injury at a comparable level, differences were found after 4 weeks. Xenon in contrast to isoflurane or ketamine anesthetized animals demonstrated a lower remodeling index (0.7 ± 0.1 vs. 0.9 ± 0.3 and 1.0 ± 0.3g/ml), better ejection fraction (62 ± 9 vs. 49 ± 7 and 35 ± 6%), and reduced expression of β-myosin heavy chain and periostin. The effects on hypertrophy, fibrosis, capillary density, and apoptosis were comparable.CONCLUSIONS: Compared to isoflurane and s-ketamine, xenon limited progressive adverse cardiac remodeling and contractile dysfunction 28 days after perioperative myocardial infarction.
AB - BACKGROUND: Xenon and isoflurane are known to have cardioprotective properties. We tested the hypothesis that these anesthetics positively influence myocardial remodeling 28 days after experimental perioperative myocardial infarction and compared their effects.METHODS: A total of 60 male Sprague-Dawley rats were subjected to 60 min of coronary artery occlusion and 120 min of reperfusion. Prior to ischemia, the animals were randomized for the different narcotic regimes (0.6 vol% isoflurane, 70 vol% xenon, or intraperitoneal injection of s-ketamine). Acute injury was quantified by echocardiography and troponin I. After 4 weeks, left ventricular function was assessed by conductance catheter to quantify hemodynamic compromise. Cardiac remodeling was characterized by quantification of dilatation, hypertrophy, fibrosis, capillary density, apoptosis, and expression of fetal genes (α/β myosin heavy chains, α-skeletal actin, periostin, and sarco/endoplasmic reticulum Ca2+-ATPase).RESULTS: Whereas xenon and isoflurane impeded the acute effects of ischemia-reperfusion on hemodynamics and myocardial injury at a comparable level, differences were found after 4 weeks. Xenon in contrast to isoflurane or ketamine anesthetized animals demonstrated a lower remodeling index (0.7 ± 0.1 vs. 0.9 ± 0.3 and 1.0 ± 0.3g/ml), better ejection fraction (62 ± 9 vs. 49 ± 7 and 35 ± 6%), and reduced expression of β-myosin heavy chain and periostin. The effects on hypertrophy, fibrosis, capillary density, and apoptosis were comparable.CONCLUSIONS: Compared to isoflurane and s-ketamine, xenon limited progressive adverse cardiac remodeling and contractile dysfunction 28 days after perioperative myocardial infarction.
KW - Anesthetics, Inhalation
KW - Animals
KW - Cardiotonic Agents
KW - Disease Models, Animal
KW - Electrocardiography
KW - Isoflurane
KW - Male
KW - Myocardial Infarction
KW - Rats
KW - Rats, Sprague-Dawley
KW - Ventricular Remodeling
KW - Xenon
U2 - 10.1097/ALN.0b013e31828744c0
DO - 10.1097/ALN.0b013e31828744c0
M3 - SCORING: Journal article
C2 - 23364599
VL - 118
SP - 1385
EP - 1394
JO - ANESTHESIOLOGY
JF - ANESTHESIOLOGY
SN - 0003-3022
IS - 6
ER -